Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

607 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Matching BRCA and prostate cancer in a public health system: Report of the Italian Society for Uro-Oncology (SIUrO) consensus project.
Lapini A, Caffo O, Conti GN, Pappagallo G, Del Re M, D'Angelillo RM, Capoluongo ED, Castiglione F, Brunelli M, Iacovelli R, De Giorgi U, Bracarda S. Lapini A, et al. Among authors: castiglione f. Crit Rev Oncol Hematol. 2023 Apr;184:103959. doi: 10.1016/j.critrevonc.2023.103959. Epub 2023 Mar 13. Crit Rev Oncol Hematol. 2023. PMID: 36921782 Review.
KRAS G12 isoforms exert influence over up-front treatments: A retrospective, multicenter, Italian analysis of the impact of first-line immune checkpoint inhibitors in an NSCLC real-life population.
Fancelli S, Caliman E, Mazzoni F, Paglialunga L, Gatta Michelet MR, Lavacchi D, Berardi R, Mentrasti G, Metro G, Birocchi I, Delmonte A, Priano I, Comin CE, Castiglione F, Bartoli C, Voltolini L, Pillozzi S, Antonuzzo L. Fancelli S, et al. Among authors: castiglione f. Front Oncol. 2022 Nov 14;12:968064. doi: 10.3389/fonc.2022.968064. eCollection 2022. Front Oncol. 2022. PMID: 36452502 Free PMC article.
Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer.
Lavacchi D, Fancelli S, Roviello G, Castiglione F, Caliman E, Rossi G, Venturini J, Pellegrini E, Brugia M, Vannini A, Bartoli C, Cianchi F, Pillozzi S, Antonuzzo L. Lavacchi D, et al. Among authors: castiglione f. Front Oncol. 2022 Nov 29;12:1055019. doi: 10.3389/fonc.2022.1055019. eCollection 2022. Front Oncol. 2022. PMID: 36523988 Free PMC article.
Therapy-Induced Stromal Senescence Promoting Aggressiveness of Prostate and Ovarian Cancer.
Pardella E, Pranzini E, Nesi I, Parri M, Spatafora P, Torre E, Muccilli A, Castiglione F, Fambrini M, Sorbi F, Cirri P, Caselli A, Puhr M, Klocker H, Serni S, Raugei G, Magherini F, Taddei ML. Pardella E, et al. Among authors: castiglione f. Cells. 2022 Dec 13;11(24):4026. doi: 10.3390/cells11244026. Cells. 2022. PMID: 36552790 Free PMC article.
Imaging and molecular features of adenomyosis after menopause.
Vannuccini S, Gabbrielli S, Castiglione F, Nardi E, Rossi M, Orlandi G, Wu E, Bertoli F, Miele V, Donati C, Petraglia F. Vannuccini S, et al. Among authors: castiglione f. Maturitas. 2024 Apr 12;185:107996. doi: 10.1016/j.maturitas.2024.107996. Online ahead of print. Maturitas. 2024. PMID: 38657487 Free article.
Dental DNA as an Indicator of Post-Mortem Interval (PMI): A Pilot Research.
Bianchi I, Grassi S, Castiglione F, Bartoli C, De Saint Pierre B, Focardi M, Oliva A, Pinchi V. Bianchi I, et al. Among authors: castiglione f. Int J Mol Sci. 2022 Oct 25;23(21):12896. doi: 10.3390/ijms232112896. Int J Mol Sci. 2022. PMID: 36361687 Free PMC article.
Biomarker characterization in endometrial cancer in Europe: first survey data analysis from 69 pathological academic and hospital labs.
Santoro A, Bragantini E, Castiglione F, Ganesan R, Matias-Guiu X, Frattini M, Gallotta V, Garcia P, Pattni Y, Tsiampali-Laprell J, Bisaro B, Barbareschi M, Zannoni GF; Collaborators (IT ESP UK, CH). Santoro A, et al. Among authors: castiglione f. Pathologica. 2024 Feb;116(1):32-45. doi: 10.32074/1591-951X-926. Pathologica. 2024. PMID: 38482673 Free PMC article.
607 results